Enhancing effects of carbon tetrachloride on in vivo mutagenicity in the liver of mice fed 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx)

Journal of Toxicological Sciences

Volumn 35, Issue 5, 2010, Pages 709-720

  Okamura, Toshiya ^a,b   Ishii, Yuji ^a   Suzuki, Yuta ^a   Inoue, Tomoki ^a   Tasaki, Masako ^a   Kodama, Yukio ^a   Nohmi, Takehiko ^a   Mitsumori, Kunitoshi ^c   Umemura, Takashi ^a   Nishikawa, Akiyoshi ^a  

^a NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

^b GIFU UNIVERSITY   (Japan)

^c TOKYO UNIVERSITY OF AGRICULTURE AND TECHNOLOGY   (Japan)

Author keywords

2 Amino 3,8 dimethylimidazo 4,5 f quinoxaline; Carbon tetrachloride; gpt delta mouse; In vivo mutagenicity

Indexed keywords

2 AMINO 3,8 DIMETHYLIMIDAZO(4,5 F)QUINOXALINE; ALANINE AMINOTRANSFERASE; CARBON TETRACHLORIDE; CYTOCHROME P450 1A2; GLUTATHIONE TRANSFERASE A4; MESSENGER RNA; PROTEIN P53; QUINOXALINE; UNCLASSIFIED DRUG;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL FOOD; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; IN VIVO STUDY; LIVER; LIVER MICROSOME; MOUSE; MUTAGENICITY; NONHUMAN; OUTCOME ASSESSMENT; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALIA; MUS;

EID: 77958077155     PISSN: 03881350     EISSN: 18803989     Source Type: Journal    
DOI: 10.2131/jts.35.709     Document Type: Article

References (38)

1. Chang, W.-C.L., Coudry, R.A., Clapper, M.L., Zhang, X., Williams, K.-L., Spittle, C.S., Li, T. and Cooper, H.S. (2007): Loss of p53 enhances the induction of colitis-associated neoplasia by dextran sulfate sodium. Carcinogenesis, 28, 2375-2381. (Pubitemid 350111597)
2. Fujii, S., Fujimori, T., Kawamata, H., Takeda, J., Kitajima, K., Omotehara, F., Kaihara, T., Kusaka, T., Ichikawa, K., Ohkura, Y., Ono, Y., Imura, J., Yamaoka, S., Sakamoto, C., Ueda, Y. and Chiba, T. (2004): Development of colonic neoplasia in p53 deficient mice with experimental colitis induced by dextran sulphate sodium. Gut, 53, 710-716. (Pubitemid 38561450)
3. Gorelick, N.J. and Mirsalis, J.C. (1996): A strategy for the application of transgenic rodent mutagenesis assays. Environ. Mol. Mutagen., 28, 434-442.
4. Hayashi, J., Aoki, H., Arakawa, Y. and Hino, O. (1999): Hepatitis C Virus and Hepatocarcinogenesis. Intervirology, 42, 205-210.
5. Hussain, S.P. and Harris, C.C. (2006): p53 biological network: At the crossroads of the cellular-stress response pathway and molecular carcinogenesis. J. Nippon Med. Sch., 73, 54-64.
6. Itoh, T., Suzuki, T., Nishikawa, A., Furukawa, F., Takahashi, M., Xue, W., Sofuni, T. and Hayashi, M. (2000): In vivo genotoxicity of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline in lacI transgenic (Big Blue®) mice. Mutat. Res., 468, 19-25.
7. Iwai, S., Karim, R., Kitano, M., Sukata, T., Min, W., Morimura, K., Wanibuchi, H., Seki, S. and Fukushima, S. (2002): Role of oxidative DNA damage caused by carbon tetrachloride-induced liver injury - enhancement of MeIQ-induced glutathione S-transferase placental form-positive foci in rats. Cancer Lett., 179, 15-24. (Pubitemid 34195648)
8. Jenks, P.J., Jeremy, A.H.T., Robinson, P.A., Walker, M.M. and Crabtree, J.E. (2003): Long-term infection with Helicobacter felis and inactivation of the tumour suppressor gene p53 cumulatively enhance the gastric mutation frequency in Big Blue® transgenic mice. J. Pathol., 201, 596-602.
9. Kanki, K., Nishikawa, A., Masumura, K., Umemura, T., Imazawa, T., Kitamura, Y., Nohmi, T. and Hirose, M. (2005): In vivo mutational analysis of liver DNA in gpt delta transgenic rats treated with the hepatocarcinogens N-nitrosopyrrolidine, 2-amino-3-methylimidazo[4,5-f]quinoline, and di(2-ethylhexyl)phthalate. Mol. Carcinog., 42, 9-17.
10. Kato, T., Miyamoto, M., Date, T., Yasui, K., Taya, C., Yonekawa, H., Ohue, C., Yagi, S., Seki, E., Hirano, T., Fujimoto, J., Shirai, T. and Wakita, T. (2003): Repeated hepatocyte injury promotes hepatic tumorigenesis in hepatitis C virus transgenic mice. Cancer Sci., 94, 649-685.
11. Kim, S.H., Cheon, H.J., Yun, N., Oh, S.T., Shin, E., Shim, K.S. and Lee, S.M. (2009): Protective effect of a mixture of Aloe vera and Silybum marianum against carbon tetrachloride-induced acute hepatotoxicity and liver fibrosis. J. Pharmacol. Sci., 109, 119-127.
12. Kleman, M., Overvik, E., Blanck, A. and Gustafsson, J.A. (1989): The food-mutagens 2-amino-1-methyl-6-phenylimidazo-[4,5-b]-pyridine (PhIP) and 2-amino-3,8-dimethylimidazo[4,5-f]-quinoxaline (MeIQx) initiate enzyme-altered hepatic foci in the resistant hepatocyte model. Carcinogenesis, 10, 1697-1700.
13. Kuroiwa, Y., Umemura, T., Nishikawa, A., Kanki, K., Ishii, Y., Kodama, Y., Masumura, K., Nohmi, T. and Hirose, M. (2007): Lack of in vivo mutagenicity and oxidative DNA damage by flumequine in the livers of gpt delta mice. Arch. Toxicol., 81, 63-69. (Pubitemid 46115459)
14. Levine, A.J. (1997): p53, the cellular gatekeeper for growth and division. Cell, 88, 323-331.
15. Lu, H., Ouyang, W. and Huang, C. (2006): Inflammation, a key event in cancer development. Mol. Cancer Res., 4, 221-233.
16. Masumura, K., Matsui, K., Yamada, M., Horiguchi, M., Ishida, K., Watanabe, M., Wakabayashi, K. and Nohmi, T. (2000): Characterization of mutations induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in the colon of gpt delta transgenic mouse: novel G:C deletions beside runs of identical bases. Carcinogenesis, 21, 2049-2056.
17. Masumura, K., Totsuka, Y., Wakabayashi, K. and Nohmi, T. (2003): Potent genotoxicity of aminophenylnorharman, formed from non-mutagenic norharman and aniline, in the liver of gpt delta transgenic mouse. Carcinogenesis, 24, 1985-1993. (Pubitemid 38008540)
18. Masumura, K., Horiguchi, M., Nishikawa, A., Umemura, T., Kanki, K., Kanke, Y. and Nohmi, T. (2003): Low dose genotoxicity of 2-amino-3,8- dimethylimidazo[4,5-f]quinoxaline(MeIQx) in gpt delta transgenic mice. Mutat. Res., 541, 91-102.
19. Montes, A.S., Corro, L.R., Rodriguez, A.S., Reyes, A.L. and Borunda, J.A. (2006): Increased DNA binding activity of NF-κB, STAT-3, SMAD3 and AP-1 in acutely damaged liver. World J. Gastroenterol., 12, 5995-6001.
20. Nishikawa, A., Suzuki, T., Masumura, K., Furukawa, F., Miyauchi, M., Nakamura, H., Son, H.Y., Nohmi, T., Hayashi, M. and Hirose, M. (2001): Reporter gene transgenic mice as a tool for analyzing the molecular mechanisms underlying experimental carcinogenesis. J. Exp. Clin. Cancer Res., 20, 111-115.
21. Nishikawa, A., Imazawa, T., Kuroiwa, Y., Kitamura, Y., Kanki, K., Ishii, Y., Umemura, T. and Hirose, M. (2005): Induction of colon tumors in C57BL/6J mice fed MeIQx, IQ, or PhIP followed by dextran sulfate sodium treatment. Toxicol. Sci., 84, 243-248.
22. Nohmi, T., Suzuki, T. and Masumura, K. (2000): Recent advances in the protocols of transgenic mouse mutation assays. Mutat. Res., 455, 191-215.
23. 32P-postlabeling method, in the liver of rats fed MeIQx. Carcinogenesis, 14, 2165-2170.
24. Ohgaki, H., Hasegawa, H., Suenaga, M., Sato, S., Takayama, S. and Sugimura, T. (1987): Carcinogenicity in mice of a mutagenic compound, 2-amino-3,8-dimethylimidazo[4,5-f] quinoxaline (MeIQx) from cooked foods. Carcinogenesis, 8, 665-668.
25. Park, C.B., Kim, D.J., Uehara, N., Takasuka, N., Hiroyasu, B.T. and Tsuda, H. (1999): Heterozygous p53-deficient mice are not susceptible to 2-amino-3,8-dimethylimidazo[4,5-f] quinoxaline (MeIQx) carcinogenicity. Cancer Lett., 139, 177-182.
26. Rich, K.J., Murray, B.P., Lewis, I., Rendell, N.B., Davies, D.S., Gooderham, N.J. and Boobis, A.R. (1992): N-hydroxy-MeIQx is the major microsomal oxidation product of the dietary carcinogen MeIQx with human liver. Carcinogenesis, 13, 2221-2226.
27. Roberts, R.A., Ganey, P.E., Ju, C., Kamendulis, L.M., Rusyn, I. and Klaunig, J.E. (2007): Role of the Kupffer cell in mediating hepatic toxicity and carcinogenesis. Toxicol. Sci., 96, 2-15.
28. Schut, H.A. and Snyderwine, E.G. (1999): DNA adducts of heterocyclic amine food mutagens: implications for mutagenesis and carcinogenesis. Carcinogenesis, 20, 353-368.
29. Shimada, T., Iwasaki, M., Martin, M.V. and Guengerich, F.P. (1989): Human liver microsomal cytochrome P-450 enzymes involved in the bioactivation of procarcinogens detected by umu gene response in Salmonella typhimurium TA 1535/pSK1002. Cancer Res., 49, 3218-3228.
30. 32P-postlabeling analysis of IQ, MeIQx and PhIP adducts formed in vitro in DNA and polynucleotides and found in vivo in hepatic DNA from IQ-, MeIQx- and PhIP-treated monkeys. Carcinogenesis, 14, 1389-1395.
31. Sone, H., Wakabayashi, K., Kushida, H., Sugimura, T. and Nagao, M. (1992): Induction of preneoplastic lesions by a low dose of 2-amino-3,8- dimethylimidazo[4,5-f]quinoxaline (MeIQx) in the livers of rats treated with carbon tetrachloride. Carcinogenesis, 13, 793-797.
32. Sugimura, T., Wakabayashi, K., Nakagama, H. and Nagao, M. (2004): Heterocyclic amines: Mutagens/carcinogens produced during cooking of meat and fish. Cancer Sci., 95, 290-299. (Pubitemid 38519467)
33. Takahashi, E., Arimoto, S., Okamoto, K. and Negishi, T. (2007): Enhancement of phase II enzyme activity by purpurin resulting in the suppression of MeIQx-DNA-adduct formation in mice. Mutat. Res., 626, 128-134.
34. Taub, R., Greenbaum, L.E. and Peng, Y. (1999): Transcriptional regulatory signals define cytokine-dependent and -independent pathways in liver regeneration. Semin. Liver Dis., 19, 117-127.
35. Tsukada, T., Tomooka, Y., Takai, S., Ueda, Y., Nishikawa, S., Yagi, T., Tokunaga, T., Takeda, N., Suda, Y. and Abe, S. (1993): Enhanced proliferative potential in culture of cells from p53-deficient mice. Oncogene, 8, 3313-3322. (Pubitemid 23342629)
36. Turesky, R.J., Lang, N.P., Butler, M.A., Teitel, C.H. and Kadlubar, F.F. (1991): Metabolic activation of carcinogenic heterocyclic aromatic amines by human liver and colon. Carcinogenesis, 12, 1839-1845.
37. Umemura, T., Kuroiwa, Y., Tasaki, M., Okamura, T., Ishii, Y., Kodama, Y., Nohmi, T., Mitsumori, K., Nishikawa, A. and Hirose, M. (2007): Detection of oxidative DNA damage, cell proliferation and in vivo mutagenicity induced by dicyclanil, a non-genotoxic carcinogen, using gpt delta mice. Mutat. Res., 633, 46-54.
38. Zhou, X.F., Wang, Q., Chu, J.X. and Liu, A.L. (2006): Effects of retrorsine on mouse hepatocyte proliferation after liver injury. World J. Gastroenterol., 12, 1439-1442.